Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface
- PMID: 3013626
- PMCID: PMC1166885
- DOI: 10.1002/j.1460-2075.1986.tb04306.x
Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface
Abstract
Polyclonal and monoclonal antibodies were raised against a synthetic peptide containing the 15 carboxy-terminal amino acids (497-511) of vesicular stomatitis virus glycoprotein (VSV-G). The polyclonal antibodies (alpha P4) reacted with epitopes distributed along the 15-residue peptide, whereas the monoclonal antibody (P5D4) reacted with one epitope containing the five carboxy-terminal amino acids. Both types of antibodies recognized the cytoplasmic domain of VSV-G synthesized by tissue culture cells infected with the temperature-sensitive 045-VSV mutant (ts045-VSV). They recognized immature forms of VSV-G in the rough endoplasmic reticulum (RER) and Golgi complex, as well as mature VSV-G at the cell surface and in budding virus. The effect of these antibodies on intracellular transport and maturation of VSV-G was studied by microinjection. Both divalent antibodies (alpha P4 and P5D4) blocked transport of VSV-G to the cell surface. Monovalent Fab' fragments of alpha P4 (alpha P4-Fabs) also interfered with the appearance of VSV-G at the cell surface; Fab fragments of P5D4 (P5D4-Fabs), however, had no inhibitory effect. These results suggest that accessibility of a cytoplasmic domain, located within the sequence of amino acids 497-506 of the carboxy-terminal tail, is essential for transport of VSV-G to the cell surface.
Similar articles
-
Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface.Cell. 1986 Sep 12;46(6):929-37. doi: 10.1016/0092-8674(86)90075-9. Cell. 1986. PMID: 3019557 Free PMC article.
-
Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.Virology. 1989 Jun;170(2):392-407. doi: 10.1016/0042-6822(89)90430-3. Virology. 1989. PMID: 2471352
-
Direct visualization of protein transport and processing in the living cell by microinjection of specific antibodies.Cell. 1984 Nov;39(1):99-109. doi: 10.1016/0092-8674(84)90195-8. Cell. 1984. PMID: 6091920
-
Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.J Virol. 2004 May;78(10):5079-87. doi: 10.1128/jvi.78.10.5079-5087.2004. J Virol. 2004. PMID: 15113889 Free PMC article.
-
Effects of transport inhibitors on the generation and transport of a soluble viral glycoprotein.Virology. 1987 Oct;160(2):482-4. doi: 10.1016/0042-6822(87)90021-3. Virology. 1987. PMID: 2821686
Cited by
-
Spatial segregation of the regulated and constitutive secretory pathways.J Cell Biol. 1989 Jul;109(1):51-60. doi: 10.1083/jcb.109.1.51. J Cell Biol. 1989. PMID: 2545730 Free PMC article.
-
Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.EMBO J. 1988 Dec 20;7(13):4119-27. doi: 10.1002/j.1460-2075.1988.tb03306.x. EMBO J. 1988. PMID: 3266596 Free PMC article.
-
Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells.J Virol. 1992 Sep;66(9):5200-9. doi: 10.1128/JVI.66.9.5200-5209.1992. J Virol. 1992. PMID: 1323689 Free PMC article.
-
Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1).Biochem J. 2002 Jun 1;364(Pt 2):497-505. doi: 10.1042/BJ20011803. Biochem J. 2002. PMID: 12023893 Free PMC article.
-
The budding mechanism of spikeless vesicular stomatitis virus particles.EMBO J. 1986 Aug;5(8):1913-20. doi: 10.1002/j.1460-2075.1986.tb04444.x. EMBO J. 1986. PMID: 3019669 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases